Watch FIFA World Cup 2026™

LIVE, FREE and EXCLUSIVE

Why is Pfizer's rollout of its anti-COVID pill so slow?

A Pfizer lab technician visually inspects Paxlovid tablet samples in Freiburg, Germany (Suppled - Pfizer).

Pfizer's COVID-19 treatment pill Paxlovid was the first pill authorized in the U-S to treat coronavirus. But since its approval, there have been questions as to why it takes so long to make. While the time frame to make the pill isn't unusual, some are wondering if supplies will improve.


Published

By Tina Quinn

Presented by Vahe Kateb

Source: SBS




Share this with family and friends


Pfizer's COVID-19 treatment pill Paxlovid was the first pill authorized in the U-S to treat coronavirus. But since its approval, there have been questions as to why it takes so long to make. While the time frame to make the pill isn't unusual, some are wondering if supplies will improve.



Latest podcast episodes

Follow SBS Armenian

Download our apps

Listen to our podcasts

Get the latest with our exclusive in-language podcasts on your favourite podcast apps.

Watch on SBS

SBS Armenian News

Watch it onDemand

Stream now